HALO EBITDA Margin - HALOZYME THERAPEUTICS, INC.

Complete source-backed ebitda margin history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA Margin

Date	EBITDA Margin
2026-06-30	60.74%
2026-03-31	50.10%
2025-12-31	-19.83%
2025-09-30	62.28%
2025-06-30	62.98%
2025-03-31	54.45%
2024-12-31	59.78%
2024-09-30	57.15%
2024-06-30	51.80%
2024-03-31	50.02%
2023-12-31	45.19%
2023-09-30	42.11%
2023-06-30	44.00%
2023-03-31	34.80%
2022-12-31	42.46%
2022-09-30	40.81%
2022-06-30	23.08%
2022-03-31	65.18%
2021-12-31	56.18%
2021-09-30	65.86%
2021-06-30	68.78%
2021-03-31	57.82%
2020-12-31	64.44%
2020-09-30	62.92%
2020-06-30	54.97%
2020-03-31	-9.33%
2019-12-31	-57.80%
2019-09-30	-50.91%
2019-06-30	-33.15%
2019-03-31	6.95%
2018-12-31	0.86%
2018-09-30	-97.33%
2018-06-30	-55.32%
2018-03-31	-74.97%
2017-12-31	66.69%
2017-09-30	13.46%
2017-06-30	-73.71%
2017-03-31	-91.06%
2016-12-31	-56.23%
2016-09-30	-69.20%
2016-06-30	-63.36%
2016-03-31	-36.89%
2015-12-31	11.34%
2015-03-31	-72.27%
2014-12-31	-11.17%
2014-03-31	-207.44%
2013-12-31	-167.95%
2013-03-31	-153.79%
2012-12-31	-18.92%
2012-03-31	-200.30%
2011-12-31	-754.15%
2011-03-31	-123.72%
2010-12-31	-490.97%

Annual EBITDA Margin

Date	EBITDA Margin
2025-12-31	34.40%
2024-12-31	55.33%
2023-12-31	42.04%
2022-12-31	41.51%
2021-12-31	62.91%
2020-12-31	55.14%
2019-12-31	-32.42%
2018-12-31	-44.08%
2017-12-31	26.27%
2016-12-31	-55.08%
2015-12-31	-19.08%
2014-12-31	-81.34%
2013-12-31	-144.54%
2012-12-31	-124.15%
2011-12-31	-33.42%
2010-12-31	-387.18%
2009-12-31	-417.04%